signific
progress
made
recent
year
understand
role
modern
mean
travel
inadvert
export
deadli
arenavirus
endem
region
basic
biolog
virus
genom
evolut
mode
transmiss
immun
suppress
diseas
pathogenesi
respons
detail
level
understand
viral
life
cycl
evolut
interact
host
immun
signal
pathway
necessari
order
design
effect
therapeut
prevent
measur
group
deadli
human
pathogen
famili
arenavirida
divid
genera
base
natur
reptarenavirida
hartmanivirida
includ
virus
infect
mammal
reptil
fish
respect
mammarenavirida
classifi
region
origin
old
world
ow
virus
found
west
africa
new
world
nw
virus
found
south
america
believ
origin
year
ago
contin
respect
figur
addit
sever
nw
arenavir
strain
discov
unit
state
suspect
potenti
caus
human
diseas
ow
nw
subgroup
polyphylet
contain
humanpathogen
nonpathogen
viral
strain
strain
total
known
caus
human
diseas
unlik
hemorrhag
fever
virus
ebola
viru
ebov
arenavir
transmiss
human
found
primarili
result
human
interact
rodent
natur
reservoir
virus
directli
observ
recent
lassa
viru
outbreak
nigeria
howev
human
human
transmiss
may
play
larger
role
certain
viral
outbreak
outbreak
strain
across
larger
geograph
area
found
cluster
close
togeth
transmiss
model
present
interest
challeng
determin
evolutionari
histori
arenavirus
mani
zoonot
virus
follow
cospeci
pattern
allow
infect
new
host
arenavirus
previous
thought
origin
asia
along
earliest
rodent
later
spread
europ
africa
america
alongsid
spread
rodent
howev
arenavir
rodent
host
phylogenet
tree
almost
never
perfectli
match
model
result
rodent
host
randomli
integr
arenavir
phylogeni
addit
lymphocyt
choriomening
viru
lcmv
found
circul
among
european
rodent
titer
lcmv
found
human
subject
worldwid
suggest
rodent
potenti
host
lcmv
widespread
previous
thought
recent
studi
reveal
lcmv
isol
tick
ukrain
china
though
low
number
posit
infect
sampl
specimen
unknown
capac
lcmv
infect
insect
cell
rais
doubt
tick
true
reservoir
rather
intermitt
viral
carrier
arenavir
evolut
therefor
may
reflect
adapt
avail
host
base
geograph
constraint
local
host
adapt
arenavirus
evidenc
recent
insight
divers
arenavirus
reptilian
marin
host
full
genom
sequenc
determin
three
reptarenavirus
isol
boa
constrictor
annul
tree
boa
ca
viru
golden
gate
viru
univers
helsinki
viru
necessit
addit
genu
reptarenavirida
arenavirida
famili
three
reptarenavirus
found
caus
agent
inclus
bodi
diseas
ibd
fatal
condit
snake
character
neurolog
abnorm
larg
eosinophil
aggreg
insid
infect
cell
consist
kda
protein
thought
reptarenavir
nucleoprotein
np
primari
sourc
lethal
secondari
infect
preliminari
evid
indic
reptarenavirus
might
specif
adapt
boa
constrictor
viral
replic
optim
reptilian
attenu
grown
mammalian
condit
infect
boa
constrictor
decreas
rate
ibd
increas
chanc
becom
asymptomat
viral
carrier
snake
speci
despit
high
viral
load
like
rodent
reservoir
reptarenavirus
also
found
transmit
vertic
wherea
genom
mammarenavirus
biseg
small
segment
larg
l
segment
reptarenavirus
potenti
complic
infect
snake
carri
differ
segment
differ
l
segment
per
individu
ad
arenavir
genom
divers
recent
discoveri
two
new
arenavirus
infect
rayfin
fish
triseg
genom
make
potenti
intermedi
arenavirus
close
cousin
viru
triseg
bunyavirida
famili
found
wide
arthropod
also
caus
sever
lethal
hemorrhag
infect
human
focu
articl
ow
nw
mammarenavirus
phylogenet
chang
viral
polymeras
mammarenavirus
may
associ
older
adapt
event
date
speciat
nw
arenavirus
current
adapt
least
ow
lassa
viru
lasv
appear
promin
associ
viral
surfac
glycoprotein
observ
recapitul
compar
genet
similar
four
arenavir
protein
figur
arenavir
polymeras
less
homolog
ow
nw
virus
well
among
ow
nw
strain
compar
arenavir
protein
suggest
earlier
genet
diverg
recent
report
support
observ
note
reassort
viru
contain
genom
segment
encod
viral
glycoprotein
gp
nucleoprotein
np
known
virul
lasv
josiah
l
genom
segment
encod
viral
polymeras
l
matrix
protein
z
known
less
virul
lasv
strain
retain
diseas
pathogen
guinea
pig
figur
contrast
anoth
reassort
viru
carri
viral
gp
np
liberian
strain
sever
attenu
taken
togeth
suggest
earlier
adapt
geograph
avail
host
requir
fundament
chang
intern
viral
protein
l
polymeras
recent
evolut
driven
optim
viral
entri
effici
immun
evas
mediat
viral
gp
np
respect
concept
viral
protein
mediat
host
immun
evas
discuss
mammarenavirus
enter
host
inhal
airborn
viral
particl
eat
andor
drink
viru
contamin
food
water
respect
social
structur
arenaviru
endem
region
present
particular
challeng
viral
contain
transmiss
model
home
often
openair
space
contain
small
space
rat
cohabit
human
built
local
avail
materi
result
rodent
reservoir
move
easili
home
home
previou
survey
found
signific
number
home
contain
rodent
reservoir
instanc
contact
rodent
rodent
wast
product
particularli
night
activ
rodent
highest
level
rice
often
stabl
crop
endem
area
particularli
western
africa
typic
grown
field
lowli
swamp
encourag
rodent
habit
challeng
present
educ
commun
infrastructur
endem
region
also
prevent
optim
diseas
control
recent
survey
find
resid
nigerian
urban
town
inadequ
knowledg
lassa
fever
poor
control
practic
practic
hunt
rodent
food
use
sacrifici
ceremoni
also
document
increas
risk
infect
futur
measur
diseas
prevent
need
focu
enforc
individu
habit
rodent
control
also
encourag
larger
polit
incent
polici
conduc
foster
sensibl
habit
infrastructur
build
diagnost
laboratori
capabl
carri
viral
genom
pcr
detect
arenavir
infect
often
avail
endem
region
comput
model
region
risk
arenavir
pandem
also
continu
necessari
predictiveprevent
measur
sever
model
studi
indic
sever
african
region
close
proxim
current
endem
region
seriou
risk
arenaviru
spread
new
reservoir
human
pathogen
arenavirus
continu
found
ad
potenti
interregion
spread
howev
biggest
factor
restrict
arenavir
pandem
appear
strong
interspeci
host
transmiss
barrier
current
model
suggest
rodent
endem
area
seroposit
local
arenavirus
rodent
clear
viru
time
period
significantli
shorter
life
span
produc
antibodi
preliminari
evid
suggest
antiarenavir
antibodi
may
small
correl
decreas
surviv
increas
rodent
captur
increas
concern
potenti
arenavirus
spread
across
region
initi
worldwid
pandem
lasv
remain
document
arenaviru
import
travel
visit
endem
region
varieti
reason
supplement
tabl
document
case
occur
prior
recent
case
lassa
fever
import
report
unit
state
pennsylvania
minnesota
georgia
ghana
sweden
germani
common
theme
among
case
secondari
infect
yet
document
intermitt
period
remiss
initi
treatment
reemerg
symptom
present
potenti
risk
protract
diseas
transmiss
salient
fact
arenavirus
also
potenti
use
biolog
weapon
particular
concern
endem
region
engag
constant
polit
militari
conflict
humantohuman
transmiss
although
rare
occurr
document
use
contamin
medic
instrument
standard
special
medic
procedur
organ
transplant
whole
threat
arenavir
spread
export
endem
region
concern
public
health
consider
despit
natur
barrier
current
help
curb
major
outbreak
arenavirus
envelop
ambisens
singlestrand
rna
virus
structur
consist
membran
envelop
contain
surfac
glycoprotein
gp
subunit
surround
capsid
consist
z
matrix
protein
figur
insid
capsid
l
rnadepend
rna
polymeras
l
rdrp
viral
biseg
genom
encapsul
nucleoprotein
np
cell
entri
mediat
gp
first
express
glycoprotein
precursor
complex
gpc
host
subtilas
proteolyt
cleav
gpc
three
final
subunit
ssp
stabl
signal
peptid
form
heterotrim
cell
membran
surfac
form
spike
protrud
viral
envelop
respons
interact
entri
receptor
class
fusion
transmembran
protein
virtu
helix
domain
ssp
unusu
small
hydrophob
longliv
signal
protein
implic
viral
fusion
transport
gpc
complex
contain
golgi
gpc
fold
chaperon
recombin
arenavirus
express
ssp
differ
strain
viabl
recombin
virus
express
nonarenavir
signal
peptid
indic
specif
adapt
ssp
arenavir
protein
observ
strengthen
work
laboratori
show
certain
ssp
residu
attenu
viral
growth
independ
cell
entri
effici
illustr
multipl
role
ssp
viral
life
cycl
remain
fulli
elucid
also
contain
nglycosyl
residu
multipl
site
ssp
myristoyl
purpos
posttransl
modif
yet
describ
detail
glycosyl
link
viral
protein
transport
ssp
myristoyl
found
vital
direct
membran
anchor
viral
fusion
lasv
lcmv
first
discov
util
cellular
entri
receptor
later
confirm
case
ow
clade
c
nw
arenavirus
figur
glycosyl
glycosyltransferas
larg
necessari
recognit
arenavirus
mimic
interact
natur
ligand
laminin
regul
appear
drive
genet
forc
arenavir
endem
region
widescal
genom
studi
found
evid
posit
select
polymorph
larg
regulatori
protein
nigerian
popul
ctermin
subunit
directli
interact
ctermin
subunit
found
critic
stabil
complex
residu
first
residu
found
import
interact
xray
crystallographi
analysi
later
identifi
loop
structur
specif
residu
respons
directli
interact
residu
also
found
critic
cell
entri
residu
locat
angstrom
away
loop
given
fulllength
gp
requir
cellular
entri
theoriz
extra
residu
may
facilit
cell
entri
complex
unknown
mechan
involv
full
length
protein
support
idea
residu
trimer
interfac
gp
recent
found
also
critic
cell
entri
highlight
import
full
gp
effici
cell
entri
endosom
cellular
protein
identifi
critic
host
factor
mediat
phswitch
mechan
viruscellular
membran
fusion
endocytosi
virion
particl
partli
explain
previou
observ
chicken
cell
line
among
abl
infect
lasv
lack
express
conserv
histidin
residu
subunit
among
ow
arenavirus
found
mediat
recognit
structur
analysi
found
shift
conform
follow
interact
possibl
serv
immun
cloak
mechan
anoth
interest
mechan
also
propos
lasv
endocytosi
rais
ph
threshold
acid
endocytosi
therebi
increas
viru
yield
prevent
deactiv
virus
acid
environ
insid
endosom
addit
host
factor
possibl
altern
entri
receptor
also
identifi
entri
arenavirus
might
involv
sodium
hydrogen
exchang
phosphatidylserin
receptor
axl
need
analys
recent
studi
also
found
cellular
factor
appear
serv
substitut
mediat
entri
lujo
viru
lujv
implic
conserv
similar
mechan
virus
well
import
conserv
mechan
viral
evolut
nw
arenavirus
use
differ
cellular
entri
receptor
depend
clade
clade
b
nw
arenavirus
pathogen
human
found
use
human
transferrin
receptor
nonpathogen
clade
b
virus
use
ortholog
number
viral
receptor
host
factor
also
found
allow
junin
viru
junv
entri
major
candid
cellular
receptor
dcsignlsign
voltageg
calcium
channel
protein
involv
clathrinmedi
pathway
endocyt
pathway
possibl
cofactor
recent
identifi
sirna
screen
inhibitor
nw
arenavir
cell
entri
yet
undetermin
mechan
receptor
clade
nw
arenavirus
still
unknown
though
shown
tent
clade
virus
use
viral
particl
enter
cell
clathrinmedi
pathway
nw
arenavirus
clathrinindepend
mechan
involv
format
multivesicular
bodi
late
endocytosi
escrt
sort
pathway
virus
figur
disassoci
viral
particl
upon
exposur
acid
ph
expos
residu
prior
viral
fusion
viral
fusion
ensu
hydrophob
region
well
cytosol
tail
found
play
critic
role
replic
viral
genom
occur
cytosol
follow
releas
endosom
viral
np
l
protein
minimum
known
compon
requir
viral
genom
replic
transcript
viral
z
protein
inhibitor
viral
polymeras
transcript
initi
function
viral
genom
rna
structur
element
play
import
role
regulatori
mechan
viral
genom
replic
transcript
gene
express
untransl
region
utr
arenavir
genom
contain
complementari
sequenc
predict
form
panhandl
structur
requir
effect
viral
rna
replic
transcript
specif
nucleotid
locat
termin
utr
lcmv
genom
found
serv
minim
requir
promot
element
sequenc
locat
complementari
utr
form
panhandl
structur
appear
requir
effici
genom
synthesi
foscaldi
colleagu
report
utr
tacarib
viru
tcrv
appear
contain
translat
stimulatori
signal
wherea
sequenc
within
utr
downregul
viral
gene
express
intergen
region
igr
fold
hairpin
secondari
structur
thought
help
termin
transcript
protect
uniqu
nonpolyadenyl
viral
mrna
transcript
degrad
cellular
exoribonucleas
sequenc
appear
larg
toler
sequenc
variat
exploit
develop
attenu
vaccin
candid
noteworthi
viral
genom
replic
genom
primer
slip
backward
initi
bind
site
result
nontempl
ppgpp
residu
thought
act
viral
rna
decoy
competit
inhibit
viral
rna
sens
cellular
innateimmun
machineri
molecular
mechan
viral
rna
sens
innat
immun
evas
strategi
arenavirus
well
effort
develop
vaccin
discuss
detail
local
arenavir
rna
also
found
import
replic
control
sens
antisens
rna
associ
cytosol
compart
contain
viral
np
host
factor
involv
rna
metabol
regard
recent
advanc
antibodymedi
dsrna
visual
well
specif
probe
genom
antigenom
arenavir
rna
show
much
promis
elucid
dynam
arenavir
rna
infecti
life
cycl
preliminari
evid
suggest
time
viral
rna
replic
regiment
control
mechan
np
l
gene
transcrib
translat
first
directli
negativesens
viral
genom
wherea
gpc
z
express
sever
hour
later
viral
genom
rna
segment
encod
gene
replic
transcrib
figur
addit
viral
infect
cell
appear
amplifi
viral
gene
cyclic
wave
express
viral
clearanc
molecular
mechan
unclear
futur
studi
area
includ
method
develop
optim
order
imag
rna
speci
lower
copi
number
expand
rna
repertoir
avail
target
imag
viral
rna
replic
transcrib
translat
virion
assembl
ensu
mediat
viral
host
cellular
protein
ctermin
domain
viral
z
matrix
protein
central
player
viral
assembl
bud
releas
infect
cell
zl
interact
znp
interact
zgp
interact
shown
ensur
coloc
viral
protein
assembl
z
interact
cellular
escrt
pathway
protein
allow
viral
bud
process
begin
aid
myristoyl
residu
nterminu
z
allow
interact
cellular
membran
z
protein
also
found
capabl
selfbud
product
viral
like
particl
vlp
absenc
viral
rna
protein
indic
z
necessari
suffici
bud
recent
report
suggest
late
domain
locat
ctermin
part
z
protein
may
also
requir
releas
socal
defect
interf
di
virion
particl
infect
cell
necessarili
releas
infecti
virion
process
may
regul
phosphoryl
certain
residu
viral
z
protein
di
particl
produc
mani
virus
includ
arenavirus
infect
similar
infecti
virion
particl
appear
protein
content
produc
product
infect
genom
contain
larg
deleteri
delet
delet
observ
region
lcmv
genom
potenti
elsewher
viral
genom
specif
function
inhibit
viral
replic
yet
studi
detail
arenavirus
found
produc
high
level
di
particl
cell
cultur
anim
infect
model
di
particl
theoriz
contribut
viral
persist
mammarenavir
diseas
profil
tend
heterogen
lassa
fever
sever
arenavir
diseas
estim
caus
case
death
per
year
endem
region
west
africa
recent
outbreak
occur
nigeria
result
laboratori
confirm
case
includ
health
care
worker
overal
fatal
rate
previou
outbreak
record
lower
mortal
rate
hospit
patient
howev
fatal
rate
high
among
infect
women
third
trimest
pregnanc
maternalfet
transmiss
arenavirus
demonstr
rodent
model
well
one
recent
report
case
human
mani
complic
aris
sever
arenavir
infect
includ
liver
vascular
damag
recapitul
guinea
pig
arenavir
anim
model
well
immunocompromis
mice
novel
hamster
nw
arenaviru
model
liver
damag
tend
highli
promin
infect
ow
arenavirus
platelet
factor
heme
breakdown
product
signific
biomark
lasv
diseas
hemorrhag
vascular
damag
occur
frequent
nw
arenaviru
infect
figur
sensorineur
hear
loss
snhl
also
occur
survivor
lassa
fever
may
attribut
pathogen
inflammatori
respons
auditori
nervou
system
neurolog
complic
also
report
arenavir
infect
monocyt
cell
alveolar
macrophag
dendrit
cell
earliest
target
arenavir
cell
entri
howev
cell
activ
upon
viral
entri
evidenc
lack
increas
level
activ
marker
hla
well
cytokin
reason
monocyt
cell
thought
act
viral
reservoir
earli
infect
viru
easili
enter
viru
later
spread
cell
enter
drain
lymph
node
failur
cell
becom
activ
consist
observ
gener
immunodepress
sever
fatal
infect
individu
viru
replic
also
directli
observ
number
cell
type
includ
respiratori
epitheli
cell
follow
infect
human
anim
model
studi
human
rodent
survivor
mammarenavir
infect
indic
proper
function
immun
respons
innat
tcell
mediat
immun
critic
minim
viral
growth
rate
present
symptom
mortal
rate
innat
immun
respons
compil
nonspecif
defens
mechan
foreign
antigen
critic
earli
detect
inhibit
pathogen
growth
adapt
immun
respons
time
produc
proper
cellmedi
immun
develop
antibodi
cytotox
tlymphocyt
respons
ctl
invad
pathogen
andor
pathogeninfect
cell
innat
immun
enact
within
hour
host
recognit
pathogenassoci
molecular
pattern
pamp
common
viral
pamp
recogn
immun
cell
uniqu
molecular
featur
viral
genom
triphosphoryl
rna
doubl
strand
rna
figur
pattern
recognit
receptor
protein
prr
rigilik
receptor
rlr
rigi
activ
pamp
result
cytokin
express
activ
recruit
innat
immun
cell
macrophag
neutrophil
dendrit
cell
rigi
upon
bind
pamp
dsrna
cytosol
process
viral
replic
chang
conform
close
open
activ
state
activ
rlr
rigi
initi
sever
complex
molecular
cascad
includ
activ
mitochondri
antivir
signal
protein
mav
eventu
result
transloc
transcript
factor
interferonregulatori
factor
irf
well
nuclear
factor
kappa
b
nfkb
nucleu
cell
activ
express
type
interferon
includ
wide
varieti
interferon
stimul
gene
isg
recent
studi
suggest
may
primarili
involv
inhibit
viral
growth
earli
stage
viral
infect
may
control
viral
growth
later
stage
infect
secret
bound
receptor
ifnar
surfac
either
cell
neighbor
cell
activ
ifn
signal
cascad
posit
feedback
loop
produc
antivir
gene
product
order
confer
viru
resist
ow
arenavir
infect
eg
lasv
patient
moder
sever
symptom
associ
inhibit
innat
immun
respons
decreas
level
proinflammatori
cytokin
figur
import
signal
control
arenavirus
appear
conserv
mammal
wildtyp
wt
mice
exhibit
symptom
arenavir
infect
ifn
receptor
ifnar
knockout
ko
mice
found
succumb
diseas
addit
vivo
infect
nonhuman
primat
nph
guinea
pig
lasv
soromba
strain
isol
local
rodent
mali
africa
show
signific
increas
cytokin
signal
decreas
mortal
compar
lasv
strain
mice
infect
ow
lcmv
capabl
maintain
persist
infect
low
level
signal
display
burst
h
infect
day
peak
viral
titer
suggest
signal
import
inhibit
viral
prolifer
earliest
stage
infect
differ
immun
respons
rodent
human
one
key
aspect
activ
investig
rodent
reservoir
gener
experi
sever
symptom
ow
arenavir
infect
mice
must
immunodefici
experi
signific
symptom
lasv
infect
mice
also
experi
earli
upregul
cell
adhes
molecul
peripher
blood
mononuclear
cell
pbmc
consist
immun
cell
recruit
site
infect
nw
arenavirus
differ
ow
strain
tend
produc
increas
level
cytokin
proinflammatori
respons
favor
inhibit
viral
prolifer
figur
virusinfect
cell
cultur
well
fatal
infect
patient
shown
consist
upregul
level
howev
macrophag
infect
vitro
nw
arenavirus
fail
show
upregul
arenavir
np
found
inhibit
pathway
crystal
structur
lasv
np
subsequ
function
studi
reveal
exoribonucleas
domain
locat
within
ctermin
domain
preferenti
degrad
dsrna
nterminu
np
contain
uniqu
domain
bind
ssrna
propos
bind
mrna
cap
structur
np
directli
interact
rigi
recent
work
lab
demonstr
np
prevent
potenti
rigi
function
cellular
protein
pact
exoribonucleas
domain
np
requir
inhibit
molecular
mechan
discuss
detail
next
section
exoribonucleas
domain
also
requir
np
inhibit
cellular
protein
kinas
cellular
protein
irf
pathway
abrog
exoribonucleas
domain
allow
express
normal
inactiv
macrophag
dendrit
cell
subsequ
activ
natur
killer
nk
cell
result
antigenpresent
except
npmediat
inhibit
appear
tacarib
viru
tcrv
np
initi
thought
due
varianc
exoribonucleas
residu
found
viral
protein
howev
structur
function
studi
later
demonstr
tcrv
np
effect
degrad
dsrna
inhibit
pathway
studi
collect
indic
import
pamp
dsrna
degrad
arenavir
np
inhibit
pathway
one
import
consider
determin
larger
role
np
arenavir
pathogenesi
fact
inhibit
np
also
present
strain
known
pathogen
human
exampl
np
nonpathogen
pichind
viru
picv
found
inhibit
pathway
human
cell
addit
work
laboratori
demonstr
exoribonucleas
rnase
catalyt
residu
necessari
inhibit
pichind
np
well
optim
picv
growth
vitro
rnase
domainmut
virus
also
found
exhibit
diminish
viral
load
pathogenesi
vivo
guinea
pig
normal
experi
high
lethal
develop
human
hemorrhag
feverlik
symptom
support
high
viral
load
infect
picv
strain
even
result
gener
wt
revert
virus
implic
import
role
np
rnase
function
optim
viral
replic
altogeth
abil
np
inhibit
express
degrad
pamp
dsrna
like
conserv
across
known
arenavirus
evidenc
tight
control
gene
express
viral
rna
local
within
cell
clear
regul
viral
rna
level
local
critic
mechan
viru
life
cycl
allow
maximum
replic
without
quench
earli
cycl
innat
immun
respons
may
explain
absolut
conserv
inhibit
arenavir
np
protein
recent
studi
also
focus
role
viral
z
protein
inhibit
pathway
origin
z
protein
test
nw
arenavir
strain
junv
machupo
viru
macv
tcrv
sabia
viru
sabv
ow
lasv
lcmv
strain
found
directli
interact
rigi
inhibit
express
recent
laboratori
demonstr
z
protein
ow
nw
arenavir
strain
known
pathogen
human
directli
interact
rigi
inhibit
express
z
protein
nonpathogen
arenavir
virus
result
recapitul
primari
human
macrophag
infect
wt
chimer
picv
show
nterminu
lcmv
z
suffici
inhibit
macrophag
activ
express
chimer
z
protein
nonpathogen
picv
whole
z
protein
emerg
anoth
key
target
investig
mechan
innat
immun
suppress
arenavirus
encourag
potenti
contributor
diseas
pathogenesi
ie
potenti
virul
factor
need
character
one
area
studi
increas
attent
role
innat
immun
cell
cytokin
initi
adapt
immun
respons
mammarenavir
infect
key
pattern
emerg
preliminari
studi
arenaviru
abil
suppress
innat
immun
respons
appear
posit
correl
abil
suppress
subsequ
adapt
immun
respons
correl
inhibit
innat
immun
respons
attenu
delay
cell
respons
succumb
fatal
arenavir
infect
demonstr
human
nonhuman
primat
guinea
pig
immunodefici
mice
well
immunodefici
mice
transplant
cell
wt
mous
bonemarrow
accordingli
individu
surviv
arenavir
infect
manag
keep
viral
load
low
peak
day
infect
lasv
individu
succumb
viral
load
continu
increas
exponenti
wt
mice
lcmv
induc
robust
express
key
cytokin
type
ii
ifn
well
product
type
ii
ifn
depend
cell
illustr
close
interconnected
innat
adapt
immun
respons
also
illustr
activ
immun
respons
key
natur
resist
arenavir
infect
mice
import
innateadapt
interfac
also
recapitul
recent
coinfect
model
lcmv
e
coli
demonstr
lpsinduc
inhibitori
mechan
nk
cell
significantli
attenu
lcmv
specif
cell
respons
vital
infect
mice
cell
found
indispens
clear
arenavirus
cell
antibodi
respons
found
dispens
fact
potenti
contribut
factor
toward
arenavir
pathogen
well
failur
previou
arenavir
vaccin
candid
protect
pathogen
strain
may
skew
cell
respons
ko
mice
abl
surviv
lcmv
infect
cell
deplet
suggest
lack
ifn
signal
could
somehow
overwhelmingli
favor
lethal
cell
prolifer
determin
mechan
cell
lethal
whether
simpli
due
less
cell
activ
novel
mechan
cell
yet
determin
myeloid
dendrit
cell
mdc
vital
constitu
innateadapt
immun
respons
interfac
due
combin
larg
popul
size
robust
activ
tcell
product
tcell
activ
enhanc
certain
condit
lcmv
infect
dendrit
cell
dc
key
target
infect
lasv
like
macrophag
activ
infect
howev
featur
nt
consist
among
arenavir
strain
demonstr
welldocu
compar
model
mammarenavir
immunogen
lasv
mopeia
viru
mopv
ow
arenavirus
share
amino
acid
ident
mastomi
natalensi
african
rat
viral
reservoir
howev
mopv
nonpathogen
human
consid
potenti
lasv
vaccin
candid
nonhuman
primat
human
case
mopv
infect
ever
record
initi
studi
found
mopv
infect
monocytederiv
dendrit
cell
modc
induc
moder
activ
signific
tcell
prolifer
modctcel
cocultur
system
wherea
lasv
infect
modc
induc
low
activ
weak
delay
tcell
respons
group
research
recent
demonstr
lasv
mopv
could
replic
well
myeloid
dendrit
cell
mdc
isol
directli
pbmc
result
induc
low
level
product
lasvinfect
cell
could
activ
tcell
mdctcell
cocultur
system
howev
mopv
abl
induc
higher
level
secret
cytokin
known
induc
tcell
activ
lasvinfect
cell
cocultur
system
though
involv
monocyt
potenti
cell
type
present
cocultur
system
result
impur
could
complet
rule
regardless
observ
seem
corrobor
earlier
find
indic
dc
dispens
tcell
activ
lcmv
infect
like
lasv
lcmv
known
inhibit
innat
immun
respons
demonstr
anoth
studi
use
chimer
virus
carri
differ
gene
either
lasv
mopv
either
lasv
revers
genet
rg
mopv
rg
backbon
group
investig
shown
lasv
np
main
determin
suppress
product
mdc
consist
known
abil
known
arenavir
np
degrad
pamp
rna
via
encod
rnase
domain
therebi
suppress
product
due
fact
mdc
appear
support
product
replic
lasv
mopv
difficult
ascertain
whether
suppress
effect
due
express
viral
protein
infect
cell
differ
chimer
virus
moreov
data
could
explain
differenti
mdc
phenotyp
mdctcell
cocultur
system
lasv
mopv
chimer
viru
infect
attempt
provid
potenti
explan
observ
author
posit
variou
effici
np
rnase
domain
differ
arenavirus
suppress
product
may
explain
differ
among
arenavirus
induc
dcmediat
tcell
activ
howev
hypothesi
need
formal
test
chimer
lasv
substitut
gp
mopv
found
significantli
increas
product
may
reflect
differ
mechan
viral
detect
base
differ
innat
immun
receptor
exampl
tolllik
receptor
heterocomplex
found
respons
innat
immun
activ
recogn
gp
nw
junv
upon
viru
infect
robust
induct
innat
adapt
immun
respons
figur
implic
antivir
activ
ow
arenavirus
junv
nw
arenavirus
also
found
initi
caspasedepend
apoptosi
ow
arenavirus
fail
induc
apoptosi
induc
significantli
delay
apoptosi
figur
rel
contribut
pathway
directli
mediat
specif
cellular
receptor
viral
signal
mechan
need
character
futur
studi
contrari
earlier
find
z
protein
found
lasvmopv
chimer
viru
model
exhibit
signific
effect
immun
suppress
might
attribut
differ
infecti
model
util
worth
note
experi
chimer
virus
take
consider
potenti
differenti
gene
express
level
viral
protein
virusinfect
cell
context
chimer
viru
backbon
addit
mdc
appear
support
product
viral
replic
rais
question
whether
viral
protein
synthes
virusinfect
mdc
model
therefor
difficult
definit
discern
role
individu
viral
protein
modul
antivir
immun
uniqu
vitro
viral
infect
model
anoth
mammarenaviralhost
interact
impact
product
cellular
protein
pact
figur
pact
protein
contain
conserv
dsrna
bind
motif
dsrbm
bind
dsrna
mediat
activ
dsrnadepend
kinas
pkr
pact
shown
activ
rigi
via
interact
ctermin
repress
domain
rigi
activ
atpas
function
potent
enhanc
product
upon
viral
infect
even
though
pact
initi
identifi
cellular
bind
partner
protein
activ
pkr
activ
rigi
pact
requir
pkr
likewis
pact
also
shown
interact
stimul
cellular
dicer
protein
dicer
appear
play
import
role
pactmedi
regul
antivir
respons
pact
rigi
pull
togeth
coimmunoprecipit
assay
less
clear
whether
interact
occur
strictli
proteinprotein
interact
protein
associ
viral
andor
cellular
rna
combin
potenti
role
rna
activ
cellular
innat
immun
protein
rigi
pact
strongli
implic
recent
find
arenavir
np
requir
intact
dsrna
bind
domain
well
exoribonucleas
activ
block
pact
enhanc
rigi
function
figur
number
viral
nucleoprotein
block
pact
enhanc
rigi
function
also
requir
intact
dsrna
bind
domain
case
herp
simplex
viru
independ
rna
bind
capac
nucleoprotein
recent
laboratori
shown
arenavir
np
block
rigi
potenti
pact
exoribonucleas
domain
requir
howev
np
appear
neg
impact
pactrigi
direct
interact
suggest
np
may
inhibit
pact
indirectli
degrad
dsrna
may
associ
complex
essenti
proper
function
taken
togeth
appear
known
viral
protein
partner
pact
well
pact
cellular
protein
partner
rigi
rnabind
properti
yet
still
nt
entir
clear
whether
dsrna
bind
absolut
requir
inhibit
pactinduc
rigi
activ
studi
illustr
current
lack
detail
understand
role
differ
viral
protein
includ
arenavir
np
inhibit
pactmedi
rigi
activ
natur
dsrna
viral
cellular
may
intim
involv
process
futur
studi
exact
role
molecular
mechan
virushost
interact
via
pactrigi
pathway
serv
appeal
panantivir
therapeut
target
develop
addit
antivir
target
pact
influenc
pactpkr
mediat
stress
signal
impact
antivir
control
also
known
cellular
process
involv
cancer
physiolog
metabol
condit
current
clinic
success
antiarenavir
vaccin
antijunv
candid
strain
current
manufactur
argentinian
govern
consid
largescal
use
due
limit
target
popul
argentina
endem
junv
infect
gener
candid
human
viral
isol
use
passag
twice
guinea
pig
follow
addit
passag
suckl
mice
cell
cultur
number
uniqu
mutat
candid
origin
thought
attenu
candid
compar
parent
wt
strain
one
mutat
transmembran
domain
subunit
consist
found
suffici
attenu
mechan
attenu
yet
elucid
thought
mutat
may
affect
viral
fusion
matur
effici
equival
mutat
machupo
viru
macv
also
found
attenu
mice
suggest
attenu
mechan
may
highli
conserv
addit
presenc
mutat
ssp
subunit
along
mutat
thought
prevent
viru
revert
wild
type
sequenc
tempt
assum
similar
attenu
techniqu
appli
toward
develop
arenavir
vaccin
howev
may
limit
junv
vaccin
sever
reason
pathway
particularli
pathway
subsequ
tcell
respons
found
critic
control
arenavir
infect
mice
arenaviralassoci
immunosuppress
result
limit
tcell
respons
furthermor
junv
gp
found
contain
fewer
glycan
gp
mammarenavirus
glycan
residu
glycanrich
lasv
gp
shown
promot
neutral
antibodi
evas
strengthen
recent
observ
antijunv
antibodi
infect
patient
neutral
junv
strain
offer
neutral
nw
arenavirus
partli
due
aforement
reason
develop
effect
vaccin
pathogen
mammarenavirus
besid
junv
proven
much
challeng
earli
attempt
use
gammairradi
lasv
particl
produc
consider
humor
respons
nhp
fail
protect
fatal
lasv
challeng
similar
theme
note
across
subsequ
studi
adapt
immun
even
crossprotect
immun
induc
vaccin
subject
fail
protect
lethal
viral
challeng
novel
revers
genet
strategi
explor
overcom
obstacl
codon
optim
increas
express
viral
protein
antigen
triseg
arenavir
vector
lcmv
picv
backbon
increas
viral
attenu
singlecycl
arenavir
vector
minim
immunosuppress
exponenti
viru
replic
anoth
method
produc
candid
vaccin
develop
base
reassort
viru
known
contain
l
genom
segment
mopv
genom
segment
lasv
figur
determin
lasv
np
gp
antigen
express
reassort
viru
essenti
provid
strong
protect
immun
rodent
eg
guinea
pig
nhp
eg
marmoset
rhesu
macaqu
lethal
diseas
caus
lasv
infect
di
particl
produc
persist
infect
cell
also
found
interfer
replic
lasv
mopv
lcmv
induc
strong
cellmedi
immun
ko
mice
implic
potenti
formul
di
toward
develop
panarenavir
vaccin
lasv
candid
vaccin
includ
express
lasv
gp
np
antigen
genom
differ
recombin
virus
vesicular
stomat
viru
vsv
vaccinia
viru
mopv
yellow
fever
viru
alphaviru
replicon
inactiv
rabi
viru
shown
exhibit
variou
protect
efficaci
lasv
infect
differ
anim
model
lasv
vaccin
develop
effort
support
nonprofit
intern
organ
call
coalit
epidem
prepared
innov
cepi
includ
base
new
vaccin
platform
recombin
measlesvirusbas
vaccin
dnabas
vaccin
cepi
also
support
two
lasv
vaccin
candid
base
recombin
rvsvbase
vector
first
rvsv
construct
express
lasv
gp
antigen
base
platform
appli
express
ebov
gp
vaccin
antigen
use
ring
vaccin
trial
guinea
africa
second
anoth
rvsvlasv
gp
construct
transloc
vsvn
gene
truncat
vsvg
cytoplasm
tail
design
increas
vaccin
safeti
similar
attenu
rvsv
vector
express
singl
multipl
ebov
gp
shown
immunogen
nhp
success
protect
nhp
ebov
marburg
viru
challeng
current
publish
preclin
data
support
develop
lassa
vaccin
base
platform
cepi
also
recent
award
contract
preclin
develop
yet
anoth
lasvgp
construct
backbon
nonrepl
simian
adenoviru
preclin
inform
avail
suitabl
viral
platform
lassa
vaccin
develop
remain
seen
well
cepisupport
vaccin
perform
come
year
formid
challeng
lassa
fever
vaccin
develop
requir
develop
predominantli
tcellmedi
mechan
protect
strong
memori
tcell
respons
lasv
np
differ
strain
lasv
demonstr
survivor
lasv
infect
guinea
consist
observ
tcell
provid
partial
protect
anim
lethal
lasv
challeng
deplet
tcell
complet
abolish
protect
addit
npspecif
tcell
play
major
protect
role
mice
infect
lcmv
addit
vaccin
develop
prevent
measur
discoveri
antivir
drug
burgeon
area
arenavir
research
current
antivir
treatment
clinic
use
specif
mammarenavirus
convalesc
plasma
therapi
junv
standard
antivir
nucleosid
analog
ribavirin
favipiravir
seen
moder
clinic
success
effect
given
earliest
stage
infect
symptom
primarili
nonspecif
peptideconjug
morpholino
oligom
also
test
altern
nucleosid
analog
reduc
titer
sever
arenavirus
cell
cultur
lcmvinfect
mice
nevertheless
recoveri
document
symptom
manag
place
nucleosid
analog
due
delay
diagnosi
reach
resolut
symptom
limit
desir
use
nucleosid
analog
antivir
compound
recent
advanc
antiarenavir
drug
discoveri
focus
identifi
compound
specif
target
viral
protein
modul
activ
host
protein
bulk
arenavir
drug
discoveri
focus
small
molecul
inhibitor
mammarenavir
glycoprotein
cell
entri
seen
success
sever
differ
approach
amphipath
dna
polym
found
block
lcmv
interact
virtu
hydrophob
rather
nucleotid
sequenc
clotrimazol
deriv
tradit
target
calciumactiv
potassium
channel
also
recent
found
inhibit
arenavir
membran
fusion
howev
mechan
action
found
independ
thu
current
unclear
convers
number
compound
found
stabil
prefus
complex
format
therebi
block
phmediat
endocytosi
one
compound
found
reduc
lasv
titer
guinea
pig
infect
model
anoth
small
molecul
recent
found
inhibit
wide
varieti
arenavirus
except
strain
contain
mutat
correspond
mutat
respons
attenu
candid
suggest
could
also
affect
prefus
stabil
complex
final
also
shown
small
molecul
inhibitor
cellular
site
proteas
block
gp
process
well
serv
gener
antivir
inhibit
lipid
cholesterol
synthesi
need
viru
replic
pharmaceut
compound
also
found
disrupt
normal
function
mammarenavir
protein
given
myristoyl
necessari
zmediat
arenaviru
bud
compound
inhibit
myristoyl
enzym
found
chang
cellular
local
z
therefor
inhibit
virion
bud
infect
cell
aromat
compound
target
zincfing
motif
z
also
found
inhibit
arenavir
prolifer
varieti
mechanist
effect
character
one
compound
exampl
compound
found
induc
z
unfold
accumul
oligomer
structur
therebi
block
interact
z
host
pml
protein
allow
nuclear
bodi
form
arenavir
l
polymeras
np
arguabl
experienc
least
progress
drug
target
former
case
one
appeal
potenti
pharmaceut
target
capsnatch
mechan
arenavir
polymeras
similar
drug
alreadi
demonstr
reduc
titer
west
nile
viru
specif
viral
cap
snatch
mechan
suspicion
arenavir
cap
snatch
mechan
may
conserv
across
speci
make
cap
snatch
promis
therapeut
target
antivir
drug
develop
metal
chelat
inde
found
potent
inhibit
lcmv
l
endonucleas
domain
subsequ
cap
snatch
activ
demonstr
potenti
futur
antivir
target
viru
featur
lethal
viral
mutagenesi
also
identifi
possibl
mechan
viral
control
studi
found
drug
target
arenavir
np
one
recent
paper
identifi
compound
pyridin
librari
reduc
lcmv
titer
postcel
entri
thought
affect
np
z
unknown
mechan
drug
target
host
protein
also
explor
potenti
pharmaceut
therapeut
tyrosin
kinas
inhibitor
genistein
current
one
support
compound
phosphoryl
found
critic
viabil
nw
picv
suscept
genistein
vitro
vivo
larger
scale
drug
screen
seem
implic
cellular
kinas
inhibit
promis
antivir
target
gener
compound
affect
arenavirus
multipl
stage
viru
life
cycl
inhibitor
nucleosid
product
also
test
varieti
vitro
context
may
addit
effect
use
conjunct
nucleosid
analog
compound
nt
appear
neg
affect
vital
cell
cultur
cautious
explor
due
possibl
advers
effect
rapidli
grow
cell
vivo
final
may
possibl
target
immun
signal
protein
antivir
control
one
antitlr
inhibitor
show
limit
lcmviniti
cytokin
respons
cell
viral
replic
mice
potenti
antivir
drug
sever
side
effect
eg
neurolog
embryon
develop
due
known
cytotox
compound
great
impedi
widespread
applic
compound
treat
arenaviru
infect
futur
antiarenavir
drug
vaccin
develop
still
urgent
need
combat
deadli
human
pathogen
import
reiter
import
role
pathway
tcellmedi
immun
control
mammarenaviru
infect
pathway
also
known
critic
innat
adapt
immun
respons
rna
viru
infect
model
well
vaccin
illustr
import
futur
studi
mechan
separ
concert
addit
continu
ecolog
effort
character
phylogeni
spread
arenavirus
socioeconom
effort
increas
public
awar
capac
contain
diseas
vaccin
therapeut
develop
need
order
optim
prevent
control
measur
mammarenavirus
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
